129 related articles for article (PubMed ID: 24135637)
1. Determination of the biodistribution and dosimetry of ¹²³I-FP-CIT in male patients with suspected Parkinsonism or Lewy body dementia using planar and combined planar and SPECT/CT imaging.
Sydoff M; Lizana H; Mattsson S; Stabin MG; Leide-Svegborn S
Appl Radiat Isot; 2013 Dec; 82():300-7. PubMed ID: 24135637
[TBL] [Abstract][Full Text] [Related]
2. Combined
Nicastro N; Burkhard PR; Garibotto V
J Neurol Sci; 2018 Sep; 392():126-127. PubMed ID: 30056199
[No Abstract] [Full Text] [Related]
3. Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques?
Treglia G; Cason E; Cortelli P; Gabellini A; Liguori R; Bagnato A; Giordano A; Fagioli G
J Neuroimaging; 2014; 24(2):149-54. PubMed ID: 23163913
[TBL] [Abstract][Full Text] [Related]
4. 123I-FP-CIT brain SPECT (DaTSCAN) imaging in the diagnosis of patients with movement disorders--first results.
Jauković L; Ilić TV; Dopudja M; Ajdinović B
Vojnosanit Pregl; 2012 Feb; 69(2):157-62. PubMed ID: 22500370
[TBL] [Abstract][Full Text] [Related]
5. The value of multimodal imaging with
Miyagawa T; Przybelski SA; Maltais D; Min HK; Jordan L; Lesnick TG; Chen Q; Graff-Radford J; Jones D; Savica R; Knopman D; Petersen R; Kremers WK; Forsberg LK; Fields JA; Ferman TJ; Allen L; Parisi J; Reichard RR; Murray M; Dickson D; Boeve BF; Kantarci K; Lowe VJ
Neurobiol Aging; 2021 Mar; 99():11-18. PubMed ID: 33422890
[TBL] [Abstract][Full Text] [Related]
6. Scan without evidence of dopaminergic deficit (SWEDD) in degenerative parkinsonism and dementia with Lewy bodies: A prospective study.
Nicastro N; Burkhard PR; Garibotto V
J Neurol Sci; 2018 Feb; 385():17-21. PubMed ID: 29406901
[TBL] [Abstract][Full Text] [Related]
7. 123I-FP-CIT SPECT in the differential diagnosis between dementia with Lewy bodies and other dementias.
Brigo F; Turri G; Tinazzi M
J Neurol Sci; 2015 Dec; 359(1-2):161-71. PubMed ID: 26671107
[TBL] [Abstract][Full Text] [Related]
8. Cardiac sympathetic impairment parallels nigrostriatal degeneration in Probable Dementia with Lewy Bodies.
Camacho V; Marquié M; Lleó A; Alvés L; Artigas C; Flotats A; Duch J; Blesa R; Gómez-Isla T; Carrió I; Estorch M
Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):476-83. PubMed ID: 21150861
[TBL] [Abstract][Full Text] [Related]
9. Improved visual [(123)I]FP-CIT SPECT interpretation for evaluation of parkinsonism by visual rating of parametric distribution volume ratio images.
Meyer PT; Winz OH; Dafotakis M; Werner CJ; Krohn T; Schäfer WM
Q J Nucl Med Mol Imaging; 2011 Jun; 55(3):301-9. PubMed ID: 21532542
[TBL] [Abstract][Full Text] [Related]
10. Evolution of clinical features in possible DLB depending on FP-CIT SPECT result.
Walker Z; Moreno E; Thomas A; Inglis F; Tabet N; Stevens T; Whitfield T; Aarsland D; Rainer M; Padovani A;
Neurology; 2016 Sep; 87(10):1045-51. PubMed ID: 27511183
[TBL] [Abstract][Full Text] [Related]
11. [(123)]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies.
van der Zande JJ; Booij J; Scheltens P; Raijmakers PG; Lemstra AW
Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1060-6. PubMed ID: 26830298
[TBL] [Abstract][Full Text] [Related]
12. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies.
O'Brien JT; McKeith IG; Walker Z; Tatsch K; Booij J; Darcourt J; Marquardt M; Reininger C;
Br J Psychiatry; 2009 Jan; 194(1):34-9. PubMed ID: 19118323
[TBL] [Abstract][Full Text] [Related]
14. Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters.
Booij J; Busemann Sokole E; Stabin MG; Janssen AG; de Bruin K; van Royen EA
Eur J Nucl Med; 1998 Jan; 25(1):24-30. PubMed ID: 9396871
[TBL] [Abstract][Full Text] [Related]
15. [123I]FP-CIT (DaTscan) SPECT brain imaging in patients with suspected parkinsonian syndromes.
Hauser RA; Grosset DG
J Neuroimaging; 2012 Jul; 22(3):225-30. PubMed ID: 21410815
[TBL] [Abstract][Full Text] [Related]
16. Role of dopamine transporter imaging in routine clinical practice.
Marshall V; Grosset D
Mov Disord; 2003 Dec; 18(12):1415-23. PubMed ID: 14673877
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic accuracy of FP-CIT SPECT in patients with parkinsonism].
Ortega Lozano SJ; Martínez Del Valle Torres MD; Jiménez-Hoyuela García JM; Gutiérrez Cardo AL; Campos Arillo V
Rev Esp Med Nucl; 2007; 26(5):277-85. PubMed ID: 17910836
[TBL] [Abstract][Full Text] [Related]
18. Correlation between 123I-FP-CIT brain SPECT and parkinsonism in dementia with Lewy bodies: caveat for clinical use.
Del Sole A; Perini G; Lecchi M; Mariani C; Lucignani G; Clerici F
Clin Nucl Med; 2015 Jan; 40(1):32-5. PubMed ID: 25290294
[TBL] [Abstract][Full Text] [Related]
19.
Pardini M; Nobili F; Arnaldi D; Morbelli S; Bauckneht M; Rissotto R; Serrati C; Serafini G; Lapucci C; Ghio L; Amore M; Massucco D; Sassos D; Bonzano L; Mancardi GL; Roccatagliata L;
Eur Radiol Exp; 2020 May; 4(1):27. PubMed ID: 32363488
[TBL] [Abstract][Full Text] [Related]
20. Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB.
Thomas AJ; Attems J; Colloby SJ; O'Brien JT; McKeith I; Walker R; Lee L; Burn D; Lett DJ; Walker Z
Neurology; 2017 Jan; 88(3):276-283. PubMed ID: 27940650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
